Featured News

02.02.21

Syapse Announces $68 Million Strategic Investment with Ally Bridge Group and Northpond Ventures to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

Syapse®, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, today announced the closing of a $68 million growth equity investment to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. 

01.27.21

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform

SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflammation-mediated autoimmune diseases and is initially focused on a potentially efficacious, yet less immunosuppressive option for the treatment of RA.

01.21.21

Boston Scientific buying cardiac health company Preventice Solutions in deal worth up to $1.2B

Boston Scientific Corp. said it has agreed to acquire Preventice Solutions Inc. for $925 million up front and up to an additional $300 million in a potential commercial milestone payment. The former has been an investor in Preventice since 2015 and currently holds an equity stake of about 22%, which is expected... 

12.28.20

23andMe Raises More Than $80 Million in Equity Financing Round

DNA testing company 23andMe Inc. raised more than $80 million in equity in a financing round led by Sequoia Capital and NewView Capital. According to Securities and Exchanges Commission filings, the company offered $85 million in equity and sold about $82.5 million...

12.22.20

SomaLogic Adds $81M to Series A Financing Totaling $214M

SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81M to its current funding round with investments from a number of additional investors, for a total Series A raise of $214M. 

12.04.20

Olympus Grows Respiratory Portfolio with Acquisition of Veran Medical Technologies, Inc.

Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million.

09.30.20

Pulmonx Corporation (“Pulmonx”) today announced the pricing of its upsized initial public offering of 10,000,000 shares of its common stock at a price of $19.00 per share, for gross proceeds of $190,000,000 million, before underwriting discounts and commissions...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced it has raised $67 million in a funding round led by Accelmed Partners with participation from an unnamed strategic investor...

08.10.20

Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CARLSBAD, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB),  today announced the closing of its initial public offering of 10,147,058 shares of common stock, which includes the exercise in full of the underwriters’ option....

07.15.20

Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence

Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), today announced that it has raised $137M in a Series B financing to accelerate investment in salesforce expansion...

02.20.20

IntelyCare, a leading intelligent workforce management solution for post-acute facilities, today announced it has completed the largest venture round in the nursing technology space, raising $45M in new equity and debt financing to solve the nationwide workforce shortage. 

02.10.20

Iora Health Closes $126 Million Series F Funding Round

Boston-based Iora Health, an innovative primary care provider network with a mission to restore humanity to healthcare, today announced an investment of $126 Million as part of their latest funding round. India-based Premji Invest, the billion dollar investment group....

02.05.20

Verana Health Acquires PYA Analytics; Announces $100 Million Financing Round Led by GV

Verana Health, a technology company that is curating and analyzing real-world clinical data to advance patient care, today announced that it has acquired the technology assets and team behind PYA Analytics (PYAA). Based in Knoxville, TN, PYAA specializes....

01.13.20

Arcadia Finishes Strongest Performance Year Ever By Closing Fully-Subscribed Growth Equity Investment

Population health management technology leader Arcadia (arcadia.io) today announced at the 38th Annual J.P. Morgan Healthcare Conference that it finished 2019 by achieving its fourth consecutive year of sales over performance-to-plan while sustaining... 

Revelation Partners_Logo-01.png

255 California Street

12th Floor

San Francisco, CA 94111

Tel: 415-905-7226

  • LinkedIn

© 2020 by Revelation Partners